Warren Buffett Is Selling These 5 Stocks

4. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 81

Percentage Decrease in Stake in Q4: 79%  

AbbVie Inc. (NYSE:ABBV) markets pharma products. It is another biopharma stock that Buffett has decreased exposure to in recent months. Between October and December last year, Berkshire decreased its stake in the company by close to 80%. It now owns just over 3 million shares of AbbVie Inc. (NYSE:ABBV) worth $410 million. 

Overall, hedge funds are not on the same page with Berkshire regarding AbbVie Inc. (NYSE:ABBV) as the smart money looks bullish on the pharmaceutical company. At the end of the third quarter of 2021, 81 hedge funds in the database of Insider Monkey held stakes worth $4.1 billion in AbbVie Inc. (NYSE:ABBV).